Auto-Injector Market Research Report: By Product Type (Disposable, Reusable), Application (Anaphylaxis, Multiple Sclerosis, Diabetes, Allergies, Rheumatoid Arthritis, Others), Distribution Channel (Online Retailer, Pharmacy, Others), End-User (Home Care Settings, Hospitals & Clinics, Ambulatory Surgical Centers), and Region (Americas, Europe, Asia-Pacific, and Middle East and Africa)—Global Forecast till 2027
Intended Audience
- Auto-injectors manufacturing companies
- Auto-injectors suppliers
- Health insurance players
- Healthcare Organizations
- Healthcare Providers
- Government organizations
- Biotechnology Companies
- Research and Development (R&D) Companies
Some of the leaders in the market are
- Scandinavian Health Ltd,
- Unilife Corporation,
- Owen Mumford Ltd. (UK),
- Amedra Pharmaceuticals LLC,
- Kaleo, Inc.,
- Enbrel
Industry/Innovation/Related News
August 16, 2018 –– Teva Pharmaceuticals (Israel) announced receiving the FDA approval for its first generic epinephrine auto-injector made for the emergency treatment of allergic reactions, including anaphylaxis.
The approved product strengths generic versions of EpiPen and EpiPen Jr, is indicated for the use in adults as well as pediatric patients who weigh more than 33 pounds.
Market Segments
MRFR has segmented the Global Auto-Injectors Market into four key dynamics for an easy grasp;
By Product Type: Disposable and Reusable among others.
By Application: Anaphylaxis, Allergies, Multiple Sclerosis, and Rheumatoid Arthritis among others.
By Suppliers: Online Retailers, Pharmacy, and Retailers among others.
By Regions: Europe, North America, Asia Pacific, and Rest-of-the-World.
Geographical Analysis
The North American region accounts for the dominating market for the auto-injectors. Factors substantiating the growth of the market in the region include technological advancements and the wide uptake of technologies in the medical sector. Substantial investments in the R&D activities for the development of new injectors and the extensive uses of sensor technology in drug delivery, drive the market growth.
Owing to the factors such as high healthcare expenditures and the increasing government funding for research the auto-injectors market in North America is expected to reach USD 0.9 BN by the end of 2022.
The European region is estimated to qualify as the second-largest market for auto-injectors. Factors such as the availability of well-established healthcare infrastructure, advanced treatment facilities, and the growing demand for quality healthcare propel the market in the region. Furthermore, the growth of biologics and the emergence of biosimilars in the burgeoning pharma markets in the U.S. and Europe is a key growth driver for the growth of the auto-injectors market.
Whereas, the Asia Pacific auto-injectors market is proliferating, emerging as one of the promising markets, globally. The rising healthcare expenditure and the increase in the number of pharma companies led by the improving economic conditions are propelling the market growth in the APAC region.
read more @ https://www.marketresearchfuture.com/reports/auto-injector-market-2046
related reports
Anti-Fungal Agents Market Research Report- Forecast to 2027
Antipsychotic Drugs Market Report - Forecast to 2027
Global Pregnancy Test Kits Market Research Report Forecast To 2027
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
